phone icon  Int'l : +1 (503) 505-6949
0
Shopping Cart is Empty..
$ 0

World Advanced Wound Care and Closure Market - Opportunities and Forecasts, 2013 - 2020

 Report Code: ME 1494
 Pages: 140
 Format: PDF Exel CD_rom
 Published: Jul 2014
tab_nTables: 61
aut_nAuthor(s): Debbie Shields & Jayanti Mishra

Traditional wound care & closure and advanced wound care & closure products are used to treat acute and chronic wounds. Chronic wounds are hard to heal wounds, which take substantial time to heal and are expensive to treat. Advanced wound care & closure products are emerging as a standard solution for treating chronic wounds. Traditional wound care & closure products are being increasingly substituted with advanced wound care & closure products due to their efficacy and effectiveness in managing wounds by enabling faster healing.

Attempts to reduce the duration of hospital stays in order to limit surgical healthcare costs, and the rising inclination towards products that enhance therapeutic outcomes are driving the demand for advanced wound care & closure products. The risks associated with ineffective wound healing promote the demand for combination dressings, which is a modern trend in the market that is replacing traditional wound dressing methods.

Smith and Nephew, Kinetic Concepts, 3M, BSN medical, Covidien, ConvaTech, Derma Sciences, Integra LifeSciences, Baxter International and Coloplast are some of the major players in the global advanced wound care and closure market.

The global advanced wound care and closure market has been segmented based on type, application, end users and geography. Based on type, the global market is segmented into advanced wound closure market and advanced wound care market. According to applications, the market is segmented into Burns, Ulcers and Surgical Wounds. Based on end users, the market is segmented into hospitals & community healthcare services and home healthcare. Geographically, the market is segmented into four regions, namely North America, Europe, Asia-Pacific and LAMEA.

Wound Care

Key Benefits

  • An in-depth analysis of the current advanced wound care, and wound closure market scenario is strategically dealt to provide future market trends that would facilitate decision making 
  • Quantitative analysis of the current market trends and estimations through 2013-2020 would help strategists to design business strategies to capitalize on the prevailing opportunities in the market
  • Analysis of the market factors in various regions would bestow a deeper understanding of demographical dynamics that would influence expansion decisions. 
  • Identification of key application segments based on their potential and growth prospects would throw light on the most profitable segments to capitalize on 
  • Analysis of key strategies adopted by market players will assist in understanding the inherent business rivalry and intensity of competition prevailing among the top brands
  • Emphasis is laid on key factors affecting the growth of the global advanced wound closure and advanced wound care market. These factors are critically analyzed to gain a futuristic view of the market 
  • SWOT and competitive analysis of key players is conducted to help stakeholders to understand the inherent trends followed by their competitors and make the necessary amendments to the existing expansion plans 

Key Market Segments

Global advanced wound care and closure market is categorized into types, applications, end user and geography.

MARKET BY TYPE

  • Advanced Wound closure
    • Haemostatic and sealing agents
      • Fibrin Sealant
      • Surgical Sealant
      • Gelatin-based Sealant
      • Human Fibrinogen and Thrombin Fleece
    • Topical Tissue Adhesive
    • Wound closure devices
      • Mechanical stapling device
      • Ligating clips
      • Wound closure strips
      • Others
  • Advanced Wound care
    • Moist Wound dressings
      • Films
      • Foams
      • Hydrocolloids
      • Hydrogels
      • Collagen
      • Alginates
      • Silver Wound Dressings
    • Active Wound care
      • Skin substitutes
      • Growth factors
    • Therapy devices
      • Negative Pressure Wound Therapy 
      • Pressure relief devices
      • Others 

MARKET BY APPLICATION

  • Burns
  • Ulcers
  • Pressure ulcers
  • Diabetic ulcers
  • Venous leg ulcers
  • Arterial ulcers
  • Surgical Wounds

MARKET BY END-USER

  • Hospitals and Community Health Services
  • Home Healthcare

MARKET BY GEOGRAPHY

  • North America
  • Europe
  • Asia-Pacific
  • LAMEA

CHAPTER 1INTRODUCTION

1.1 Report Description
1.2 Reason for doing study
1.3 Key Benefits
1.4 Key Market Segments
1.5 Key Audiences
1.6 Research Methodology

1.6.1 Secondary research
1.6.2 Primary research
1.6.3 Analyst tools and models

CHAPTER 2 EXECUTIVE SUMMARY

2.1 CXO Perspective
2.2 Market beyond: What to expect by 2025

2.2.1 Moderate Growth Scenario
2.2.2 Rapid growth Scenario
2.2.3 Diminishing growth scenario

CHAPTER 3 GLOBAL ADVANCED WOUND CARE AND WOUND CLOSURE MARKET OVERVIEW

3.1 Market Definition and Scope
3.2 Treatment  of diabetic foot ulcers with Negative Pressure Wound Therapy using vaccum-assisted closure and  advanced moist wound therapy
3.3 Emergence of combination dressings
3.4 Biologics : An emerging area of Advanced wound care
3.5 Key Findings

3.5.1 Top factors impacting Global Advanced Wound closure and  wound care market
3.5.2 Top winning strategies in the  Global Advanced wound closure and wound care market
3.5.3 Top investment pockets in advanced wound closure and wound care market

3.6 Value chain analysis
3.7 Porter’s five forces analysis
3.8 Market share analysis, 2013
3.9 Case Studies

3.9.1 Use of IntraSite Conformable dressing in the management of a sloughy venous leg ulcer
3.9.2 IntraSite Conformable in the treatment of necrotic pressure ulcers

3.9.3 INTEGRA WOUND MATRIX DRESSINGS IN TYPE II DIABETIC ULCER

3.10 Global advanced wound care and wound closure market Dynamics

3.10.1 Drivers

3.10.1.1 Increase in aging population
3.10.1.2 Rise in prevalence of chronic wounds, venous ulcers,diabetic ulcers and pressure sores
3.10.1.3 Advancement in technology
3.10.1.4 Increase in volume of Surgeries

3.10.2 Restraints

3.10.2.1 Unfavourable reimbursement policies
3.10.2.2 reluctance in adoption of New technologies

3.10.3 Opportunities

3.10.3.1 Advancements in Moist dressing
3.10.3.2 Optimised physical therapies
3.10.3.3 Biological products

CHAPTER 4 ADVANCED WOUND CARE AND WOUND CLOSURE MARKET BY TYPES

4.1 Advanced Wound Closure

4.1.1 Key market trends
4.1.2 Key drivers and opportunities
4.1.3 Market size and forecast
4.1.4 Haemostatic and sealing agent

4.1.4.1 Surgical Sealant
4.1.4.2 Fibrin Sealant
4.1.4.3 Gelatin-based sealant
4.1.4.4 Human fibrinogen and thrombin fleece (HFTF)

4.1.5 Topical tissue adhesive
4.1.6 Wound closure devices

4.1.6.1 Mechanical Stapling device
4.1.6.2 Ligating clips
4.1.6.3 Wound Closure Strips
4.1.6.4 Others

4.2 Advanced Wound care

4.2.1 Key market trends
4.2.2 Key drivers and opportunities
4.2.3 Market size and forecast
4.2.4 Moist Wound dressings

4.2.4.1 Films

4.2.4.2 Foams
4.2.4.3 Hydrocolloids
4.2.4.4 Hydrogels
4.2.4.5 Collagen
4.2.4.6 Alginate Dressings
4.2.4.7 Silver wound dressings

4.2.5 Active Wound care

4.2.5.1 Skin Substitutes
4.2.5.2 Growth Factors

4.2.6 Therapy devices

4.2.6.1 Negative Pressure wound therapy
4.2.6.2 Pressure Relief devices
4.2.6.3 Others

CHAPTER 5 GLOBAL ADVANCED WOUND CARE AND ADVANCED WOUND CLOSURE MARKET BY APPLICATION

5.1 Burns
5.2 Ulcers

5.2.1 Pressure ulcers
5.2.2 Diabetic foot Ulcers
5.2.3 Venous Ulcers
5.2.4 Arterial Ulcers

5.3 Surgical Wounds
5.4 Others

CHAPTER 6 GLOBAL ADVANCED WOUND CARE AND WOUND CLOSURE MARKET BY END USER


6.1 Hospitals & Community Health Services
6.2 Home Healthcare

CHAPTER 7 GLOBAL ADVANCED WOUND CARE AND WOUND CLOSURE MARKET BY GEOGRAPHY

7.1 North America

7.1.1 Key Market Trends
7.1.2 Competitive Scenario
7.1.3 Key growth factors and opportunities
7.1.4 Market size and Forecast

7.2 Europe

7.2.1 Key market trends
7.2.2 Competitive Scenario
7.2.3 Key growth factors and opportunities
7.2.4 Market Size and Forecast

7.3 Asia Pacific

7.3.1 Key market trends
7.3.2 Competitive Scenario
7.3.3 Key growth factors and opportunities
7.3.4 Market Size and Forecast

7.4 LAMEA

7.4.1 Key market trends
7.4.2 Competitive Scenario
7.4.3 Key growth factors and opportunities
7.4.4 Market Size and Forecast

CHAPTER 8 COMPANY PROFILE

8.13 M

8.1.1 Company overview
8.1.2 Company Snapshot
8.1.3 Business Performance
8.1.4 Strategy move and development
8.1.5 SWOT Analysis of 3M

8.2 BSN Medical

8.2.1 Company overview
8.2.2 Company snapshot
8.2.3 Strategic move and development
8.2.4 SWOT Analysis of BSN Medical

8.3 Covidien

8.3.1 Company overview
8.3.2 Company snapshot
8.3.3 Business Performance
8.3.4 Strategic move and development
8.3.5 SWOT Analysis of Covidien

8.4 Kinetic Concepts

8.4.1 Company Overview
8.4.2 Company snapshot
8.4.3 Business performance
8.4.4 Strategic move and development

8.4.4.1 Primary Strategy: Product launch
8.4.4.2 Secondary Strategy : Acquisition

8.4.5 SWOT Analysis of Kinetic Concepts

8.5 ConvaTech

8.5.1 Company Overview
8.5.2 Company Snapshot
8.5.3 Business Performance
8.5.4 Strategic move and development

8.5.4.1 Principle strategy Product launch
8.5.4.2 Secondary strategy Acquisitions

8.5.5 SWOT Analysis ConvaTech

8.6 Coloplast

8.6.1 Company Overview
8.6.2 Company Snapshot
8.6.3 Business Performance
8.6.4 Strategic move and development
8.6.5 SWOT Analysis of Coloplast

8.7 Derma Sciences

8.7.1 Company overview
8.7.2 Company snapshots
8.7.3 Business Performance
8.7.4 Strategy move and development

8.7.4.1 Principle strategy: Product launch
8.7.4.2 Secondary strategy: Acquisition

8.7.5 SWOT Analysis of Derma Sciences

8.8 Integra LifeSciences

8.8.1 Company overview
8.8.2 Company Snapshot
8.8.3 Business performance
8.8.4 Strategic move and development

8.8.4.1 Principle strategy product launch
8.8.4.2 Secondary strategy acquisition

8.8.5 SWOT Analysis of Integra LifeSciences

8.9 Baxter International

8.9.1 Company Overview
8.9.2 Company Snapshot
8.9.3 Business Performance
8.9.4 Strategic move and development

8.9.4.1 Principle strategy:p product launch
8.9.4.2 Secondary strategy: Research and development

8.9.5 SWOT Analysis of Baxter International

8.10 Smith & Nephews

8.10.1 Company Overview
8.10.2 Company Snapshot
8.10.3 Business Performance
8.10.4 Strategic move and development

8.10.4.1 Principle strategy Product launch
8.10.4.2 Secondary Strategy Acquisitions

List of Tables


TABLE 1  BASE CASE ADVANCED WOUND CARE AND WOUND CLOSURE  MARKET REVENUE BY GEOGRAPHY, 2020-2025 ($MILLION)
TABLE 2  OPTISMITICS CASE ADVANCED WOUND CARE AND WOUND CLOSURE MARKET REVENUE BY GEOGRAPHY, 2020-2025 ($MILLION)
TABLE 3  CRITICAL CASE ADVANCED WOUND CARE AND WOUND CLOSURE MARKET REVENUE BY GEOGRAPHY, 2020-2025 ($MILLION)
TABLE 4  GLOBAL ADVANCED WOUND CLOSURE MARKET REVENUE BY TYPE, 2013-2020 ($MILLION)
TABLE 5  GLOBAL HAEMOSTATICS AND SEALING ADVANCED WOUND CLOSURE MARKET REVENUE BY TYPE, 2013-2020 ($MILLION)
TABLE 6  GLOBAL HAEMOSTATICS AND SEALING ADVANCED WOUND CLOSURE MARKET REVENUE BY GEOGRAPHY, 2013-2020 ($MILLION)
TABLE 7  GLOBAL SURGICAL HAEMOSTATICS AND SEALING AGENTS MARKET REVENUE BY GEOGRAPHY, 2013 – 2020 ($MILLION)
TABLE 8  GLOBAL FIBRIN HAEMOSTATICS AND SEALING AGENTS MARKET REVENUE BY GEOGRAPHY, 2013 – 2020 ($MILLION)
TABLE 9  GLOBAL GELATIN-BASED HAEMOSTATICS AND SEALING AGENTS MARKET REVENUE BY GEOGRAPHY, 2013 – 2020 ($MILLION)
TABLE 10  GLOBAL HFTF HAEMOSTATICS AND SEALING AGENTS MARKET REVENUE BY GEOGRAPHY, 2013 – 2020 ($MILLION)
TABLE 11  GLOBAL TOPICAL TISSUE ADHESIVES ADVANCED WOUND CLOSURE MARKET REVENUE BY GEOGRAPHY, 2013 – 2020 ($MILLION)
TABLE 12  GLOBAL WOUND CLOSURE DEVICES MARKET REVENUE BY TYPE, 2013-2020 ($MILLION)
TABLE 13  GLOBAL WOUND CLOSURE DEVICES MARKET REVENUE BY GEOGRAPHY, 2013-2020 ($MILLION)
TABLE 14  GLOBAL MECHANICAL STAPLING WOUND CLOSURE DEVICES MARKET REVENUE BY GEOGRAPHY, 2013 – 2020 ($MILLION)
TABLE 15  GLOBAL LIGATING CLIPS WOUND CLOSURE DEVICES MARKET REVENUE BY GEOGRAPHY, 2013 – 2020 ($MILLION)
TABLE 16  GLOBAL WOUND CLOSURE STRIPS WOUND CLOSURE DEVICES MARKET REVENUE BY GEOGRAPHY, 2013 – 2020 ($MILLION)
TABLE 17  GLOBAL OTHERS WOUND CLOSURE DEVICES MARKET REVENUE BY GEOGRAPHY, 2013 – 2020 ($MILLION)
TABLE 18  GLOBAL ADVANCED WOUND CLOSURE MARKET REVENUE BY TYPE, 2013-2020 ($MILLION)
TABLE 19  GLOBAL ADVANCED WOUND CARE MARKET REVENUE BY GEOGRAPHY, 2013 – 2020 ($MILLION)
TABLE 20  GLOBAL FILMS MOIST WOUND DRESSINGS MARKET REVENUE BY GEOGRAPHY, 2013 – 2020 ($MILLION)
TABLE 21  GLOBAL FOAMS MOIST WOUND DRESSINGS MARKET REVENUE BY GEOGRAPHY, 2013 – 2020 ($MILLION)
TABLE 22  GLOBAL HYDROCOLLOIDS MOIST WOUND DRESSINGS MARKET REVENUE BY GEOGRAPHY, 2013 – 2020 ($MILLION)
TABLE 23  GLOBAL HYDROGELS MOIST WOUND DRESSINGS MARKET REVENUE BY GEOGRAPHY, 2013 – 2020 ($MILLION)
TABLE 24  GLOBAL COLLAGENS MOIST WOUND DRESSINGS MARKET REVENUE BY GEOGRAPHY, 2013 – 2020 ($MILLION)
TABLE 25  GLOBAL ALGINATE DRESSINGS MOIST WOUND DRESSINGS MARKET REVENUE BY GEOGRAPHY, 2013 – 2020 ($MILLION)
TABLE 26  GLOBAL SILVER WOUND DRESSINGS MOIST WOUND DRESSINGS MARKET REVENUE BY GEOGRAPHY, 2013 – 2020 ($MILLION)
TABLE 27  GLOBAL ACTIVE WOUND CARE MARKET REVENUE BY TYPE, 2013-2020 ($MILLION)
TABLE 28  GLOBAL ACTIVE WOUND CARE MARKET REVENUE BY GEOGRAPHY, 2013-2020 ($MILLION)
TABLE 29  GLOBAL SKIN SUBSTITUTES ACTIVE WOUND CARE MARKET REVENUE BY GEOGRAPHY, 2013 – 2020 ($MILLION)
TABLE 30  GLOBAL GROWTH FACTORS ACTIVE WOUND CARE MARKET REVENUE BY GEOGRAPHY, 2013 – 2020 ($MILLION)
TABLE 31  GLOBAL THERAPYDEVICE MARKET REVENUE BY TYPE, 2013-2020 ($MILLION)
TABLE 32  GLOBAL THERAPY DEVICE  MARKET REVENUE BY GEOGRAPHY, 2013-2020 ($MILLION
TABLE 33  GLOBAL NPWT THERAPY DEVICES MARKET REVENUE BY GEOGRAPHY, 2013 – 2020 ($MILLION)
TABLE 34  GLOBAL PRESSURE RELIEF  THERAPY DEVICES MARKET REVENUE BY GEOGRAPHY, 2013 – 2020 ($MILLION)
TABLE 35  GLOBAL NPWT THERAPY DEVICES MARKET REVENUE BY GEOGRAPHY, 2013 – 2020 ($MILLION)
TABLE 36  GLOBAL ADVANCED WOUND CLOSURE AND WOUND CARE  MARKET REVENUE BY APPLICATION, 2013-2020 ($MILLION)
TABLE 37  GLOBAL BURNS ADVANCED WOUND CARE AND WOUND CLOSURE MARKET REVENUE BY GEOGRAPHY, 2013 – 2020 ($MILLION)
TABLE 38  GLOBAL ULCERS ADVANCED WOUND CARE AND WOUND CLOSURE MARKET REVENUE BY TYPE, 2013 – 2020 ($MILLION)
TABLE 39  GLOBAL ULCERS ADVANCED WOUND CARE AND WOUND CLOSURE MARKET REVENUE BY GEOGRAPHY, 2013 – 2020 ($MILLION)
TABLE 40  GLOBAL PRESSURE ULCERS APPLICATION MARKET REVENUE BY GEOGRAPHY, 2013 – 2020 ($MILLION)
TABLE 41  GLOBAL DIABETIC FOOT ULCERS APPLICATION MARKET REVENUE BY GEOGRAPHY, 2013 – 2020 ($MILLION)
TABLE 42  GLOBAL VENOUS ULCERS APPLICATION MARKET REVENUE BY GEOGRAPHY, 2013 – 2020 ($MILLION)
TABLE 43  GLOBAL ARTERIAL ULCERS APPLICATION MARKET REVENUE BY GEOGRAPHY, 2013 – 2020 ($MILLION)
TABLE 44  GLOBAL SURGICAL WOUNDS ADVANCED WOUND CARE AND WOUND CLOSURE MARKET REVENUE BY GEOGRAPHY, 2013 – 2020 ($MILLION)
TABLE 45  GLOBAL SURGICAL WOUNDS APPLICATION MARKET REVENUE BY GEOGRAPHY, 2013 – 2020 ($MILLION)
TABLE 46  GLOBAL OTHER APPLICATION MARKET REVENUE BY GEOGRAPHY, 2013 – 2020 ($MILLION)
TABLE 47  GLOBAL ADVANCED WOUND CLOSURE AND WOUND CARE  MARKET REVENUE BY AN, 2013-2020 ($MILLION)
TABLE 48  GLOBAL ADVANCED WOUND CLOSURE AND WOUND CARE END USER  MARKET REVENUE BY GEOGRAPHY, 2013-2020 ($MILLION)
TABLE 49  GLOBAL HOSPITALS & CHS END USER MARKET REVENUE BY GEOGRAPHY, 2013 – 2020 ($MILLION)
TABLE 50  GLOBAL HOME HEALTHCARE END USER MARKET REVENUE BY GEOGRAPHY, 2013 – 2020 ($MILLION)
TABLE 51  NORTH AMERICA ADVANCED WOUND CARE AND WOUND CLOSURE  MARKET REVENUE BY APPLICATION, 2013-2020 ($MILLION)
TABLE 52  EUROPE ADVANCED WOUND CARE AND WOUND CLOSURE  MARKET REVENUE BY APPLICATION, 2013-2020 ($MILLION)
TABLE 53  ASIA-PACIFIC ADVANCED WOUND CARE AND WOUND CLOSURE  MARKET REVENUE BY APPLICATION, 2013-2020 ($MILLION)
TABLE 54  LAMEA ADVANCED WOUND CARE AND WOUND CLOSURE  MARKET REVENUE BY APPLICATION, 2013-2020 ($MILLION)
TABLE 55  3M SNAPSHOT
TABLE 56  BSN SNAPSHOT
TABLE 57  COVIDIEN SNAPSHOT
TABLE 58  KINETIC CONCEPTS SNAPSHOT
TABLE 59  CONVATECH SNAPSHOT
TABLE 60  COLOPLAST SNAPSHOT
TABLE 61  DERMASCIENCES SNAPSHOT
TABLE 62  INTEGRA LIFESCIENCES SNAPSHOT
TABLE 63  BAXTER SNAPSHOT


List of Figures


FIG. 1  TOP IMPACTING FACTOR (2020-2025)
FIG. 2  TOP IMPACTING FACTORS, OPTIMISTIC CASE (2020-2025)
FIG. 3  TOP IMPACTING FACTOR, CRITICAL CASE (2020-2025)
FIG. 4  TOP FACTORS IMPACTING GLOBAL ADVANCED WOUND CLOSURE AND WOUND CARE MARKET, 2013-2020
FIG. 5  TOP WINNING STRATEGIES IN GLOBAL ADVANCED WOUND CLOSURE AND WOUND CARE MARKET, 2013-2020
FIG. 6  VALUE CHAIN ANALYSIS
FIG. 7  PORTER’S FIVE FORCES ANALYSIS
FIG. 8  3M REVENUE BY BUSINESS SEGMENTS
FIG. 9  3M REVENUE BY GEOGRAPHY
FIG. 10  SWOT ANALYSIS OF 3M
FIG. 11  SWOT  ANALYSIS OF BSN MEDICAL
FIG. 12  COVIDIEN REVENUE BY BUSINESS SEGMENTS
FIG. 13  COVIDIEN REVENUE BY GEOGRAPHY
FIG. 14  SWOT ANALYSIS OF COVIDIEN
FIG. 15  KINETIC CONCEPTS REVENUE BY BUSINESS SEGMENT
FIG. 16  SWOT ANALYSIS OF KINETIC CONCEPTS
FIG. 17  CONVATECH REVENUE BY BUSINESS SEGMENTS
FIG. 18  SWOT OF CONVATECH
FIG. 19  COLOPLAST REVENUE BY BUSINESS SEGMENTS
FIG. 20  DERMA SCIENCES REVENUE BY BUSINESS SEGMENTS
FIG. 21  SWOT ANALYSIS OF DERMA SCIENCES
FIG. 22  REVENUE BY GEOGRAPHY
FIG. 23  INTEGRA LIFESCIENCES REVENUE BY SEGMENTS IN US
FIG. 24  SWOT ANALYSIS OF INTEGRA LIFESCIENCES
FIG. 25   BAXTER INTERNATIONAL REVENUE BY BUSINESS SEGMENTS
FIG. 26 BAXTER INTERNATIONAL REVENUE BY GEOGRAPHY
FIG. 27 SWOT ANALYSIS OF BAXTER INTERNATIONAL
FIG. 28 SMITH & NEPHEWS REVENUE BY BUSINESS SEGMENTS
FIG. 29 SMITH & NEPHEWS REVENUE BY GEOGRAPHY
FIG. 30 SWOT OF SMITH AND NEPHEWS

Advanced wound care and closure products have emerged as the promising solution in wound management. Wound closure devices, Haemostatic and sealing agents, and topical adhesives has proven their effectiveness in wound closing over traditional sutures and stapling wound closures as these advanced wound closures support scar free surgeries and offer number of benefits over conventional solutions. Moist wound dressings and composite dressings has changed the wound healing process. Traditional dressings are being increasingly substituted with moist and composite wound dressings, mainly due to their effectiveness in managing wounds by promoting faster healing. Active wound care has emerged as a most potent segment of advanced wound care and would become most preferable solution for wound management. Therapy devices such as Negative Pressure Wound Therapy systems, Pressure relief devices and other devices under clinical studies are the noval approach in the wound management. Rising lifestyle diseases that lead to chronic wounds such as diabetic foot ulcers and growing number of cosmetic, plastic and other surgical procedures has boosted the market growth. However, Reimbursement for advanced wound care and wound closure products is complex as these products are very expensive and experiencing significant price pressures.

SINGLE USER
GROUP LICENSE
SITE LICENSE
GLOBAL LICENSE
$4515
$5325
$7350
$10680
SUPPORT
Delivery Formats
20% Free customization (Pre-sale)
16 Analyst hour support (Post Sale)
40 Analyst hour support (Post Sale)
160 hours of mini-consult
Free quarterly industry update
Free report on update (within 180 days)
MULTIPLE PURCHASE
Complimentary report with 2 reports
Complimentary report with 3 reports
Subscription Model
Have questions ?
connect
Need to add more ?
request

Get This Report
buy now
First time buyer ?
Check offers and discount
on this report
GET DISCOUNT
Need More Information
phone_n +1 (503) 505-6949

Help AMR help@alliedmarketresearch.com
Or
Send Enquiry
WHY ALLIED MARKET RESEARCH?
Infallible Methodology
To ensure high level data integrity, accurate analysis and impeccable forecasts
ANALYST SUPPORT
For complete satisfaction
CUSTOMIZATION
On-demand customization of scope of the report to exactly meet your needs
TARGETED MARKET
Targeted market view to eliminate redundant information to provide valued information and save time of the reader
RECENTLY VIEWED REPORTS
get_n
SIMILAR MARKET REPORTS
  • ...
    In-vitro fertilization is a type of assisted reproductive technology that helps women in conceiving. The global IVF market was valued at $9.3 billion in 2012 and is expected to grow up to $21.6 billion by 2020. Delayed pregnancy in women is one of the major driving factors of the IVF market, as the chances of conceiving lowers with age. The pregnancy success rate with IVF technique is higher in the age group of 35-39.Globally, the number of couples with infertility issues was found to be 48.5 million in 2010.
    Jan 2014 | Price: $4515(SU) €0(SU) £0(SU) | View Details >>
  • ...
    RNA based therapeutics has garnered significant attention in the recent years due to its potential to treat variety of chronic diseases such as cancer, diabetes, AIDS, Tuberculosis and certain cardiovascular conditions. Despite being in the clinical research phase, the RNA based therapeutics is been explored as a promising treatment option for the diseases which are difficult to treat.
    Sep 2014 | Price: $4515(SU) €0(SU) £0(SU) | View Details >>
  • ...
    Intravenous Immunoglobulin (IVIG) is a sterile solution of antibodies collected from healthy donors, which is administered through the veins into the body. Currently, the immunoglobulin industry is growing on account of increasing FDA/EMA approvals and government support. IVIG usage against the conditions within the criteria (i.e. FDA/EMA approved indications) have increased greatly and the largest increase found in Chronic Inflammatory demyelinating polyneuropathy (CIDP), Hypogammaglobulinemia and immunodeficiency diseases.
    Apr 2015 | Price: $4515(SU) €0(SU) £0(SU) | View Details >>
  • ...
    Biomarkers are novel diagnostic tools that provide intelligence to physician about disease progression and treatment effects. Advancement in understanding of human genome promotes its application in diagnosis of disease on molecular basis. Biomarker technology is evidencing increased application in disease diagnosis, drug development and formulation, diagnosis for exposure of certain harmful chemical and prognostic treatments. The global market for diagnostic biomarker is expected to reach about $30.6 billion in 2020, growing at CAGR of 16% from 2013 to 2020.
    Dec 2013 | Price: $4515(SU) €0(SU) £0(SU) | View Details >>
ON DEMAND REPORTS
  • ...
    DNA sequencing is a process used to determine the order of nucleotides within DNA molecules. Prenatal DNA sequencing is the method of sequencing the DNA isolated from pregnant women’s blood to reveal the full genetic code of a fetus. Prenatal DNA sequencing is used to sequence the whole genome of unborn baby that effectively detects the diseases
    Oct 2015 | View Details >>
  • ...
    One of the early symptoms of urinary tract cancer is the presence of blood in the urine, haematuria. As cited in WHO report urinary tract cancer was the ninth-most highly occurent cancer types in 2012 and have high reoccurrence rate as well. The risk of acquiring bladder cancer is high among smokers, aging population, workers at chemical industry, and among people with urinary tract infections.
    Oct 2015 | View Details >>
  • ...
    Non-invasive diagnostics is a process of identifying the disease conditions with minimal incision to the body during diagnosis. Non-invasive diagnostic market is segment of diagnostic market, which was valued at approximately $46 billion in 2011. The non-invasive diagnostic market is mainly driven by increasing rate of prevalence of chronic disease such as CVD, Neurological disease. More than 64.4 million people are suffering from various type of CVD in the U.S, out of which nearly 2,600 people die in a day. The growth of non-invasive diagnostics market has been hindered by availability of non-invasive diagnostic services. Developing countries are not getting non-invasive diagnostic services due to lack of awareness.
    Oct 2015 | View Details >>
  • ...
    Antipsychotic drugs are also termed as major tranquilizers or neuroleptics and these are primarily used to treat psychosis. The common psychotic disorders, where these drugs are majorly used include schizophrenia, hallucinations, delusions, bipolar disorder and others.
    Oct 2015 | View Details >>